SCHEMBL2833468

SCHEMBL2833468

COC(=O)c1ccc(C(=O)NCc2ccc(C(=O)NNC(=O)O)cc2)cc1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.67
KMT2A Q03164 2/20 0.67
SMN1; SMN2 Q16637 1/20 0.67
HDAC1 Q13547 5/20 0.60
HDAC6 Q9UBN7 3/20 0.60
HDAC3 O15379 4/20 0.56
LMNA P02545 1/20 0.54
RAB9A P51151 3/20 0.53
NPC1 O15118 2/20 0.53
HDAC2 Q92769 2/20 0.53
MAPK14 Q16539 1/20 0.53
NR1H4 Q96RI1 4/20 0.51
EPHX2 P34913 3/20 0.51
ALDH1A1 P00352 1/20 0.51
TDP1 Q9NUW8 1/20 0.51
CA1 P00915 1/20 0.51
CA2 P00918 1/20 0.51
L3MBTL1 Q9Y468 1/20 0.51
MAPT P10636 2/20 0.51
CYP2C9 P11712 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13947386 0.86 ALDH1A1 (0.66) MEN1KMT2ASMN1; SMN2LMNARAB9A
SCHEMBL2833527 0.86 KMT2A (0.68) MEN1KMT2ASMN1; SMN2HDAC1HDAC6
SCHEMBL21454776 0.86 MEN1 (0.77) MEN1KMT2ASMN1; SMN2HDAC1HDAC6
SCHEMBL4749069 0.84 KMT2A (0.74) MEN1KMT2ASMN1; SMN2HDAC1HDAC6
SCHEMBL28684197 0.83 EPHX2 (0.68) MEN1KMT2ASMN1; SMN2HDAC1HDAC6
SCHEMBL6245709 0.83 MEN1 (0.63) MEN1KMT2ASMN1; SMN2RAB9ANPC1
SCHEMBL2832940 0.82 MEN1 (0.57) MEN1KMT2ASMN1; SMN2HDAC1HDAC6
SCHEMBL4241219 0.82 MEN1 (0.63) MEN1KMT2ASMN1; SMN2HDAC1HDAC6
SCHEMBL18259860 0.82 KMT2A (0.63) MEN1KMT2ASMN1; SMN2HDAC1HDAC6
SCHEMBL4234328 0.82 MEN1 (0.63) MEN1KMT2ASMN1; SMN2HDAC1HDAC6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100168101-A1 OXINDOLE HYDRAZIDE MODULATORS OF PROTEIN TYROSINE PHOSPHATASES (PTPS) APPLIED RESEARCH SYSTEMS ARS HOLDING N.V. (NL) 2010-07-01 US claimed
EP-1439834-A1 OXINDOLE HYDRAZIDE MODULATORS OF PROTEIN TYROSINE PHOSPHATASES (PTPS) Applied Research Systems ARS Holding N.V. (AN) 2004-07-28 EP claimed
WO-2003037328-A1 OXINDOLE HYDRAZIDE MODULATORS OF PROTEIN TYROSINE PHOSPHATASES (PTPS) APPLIED RESEARCH SYSTEMS ARS HOLDING N.V. (NL) 2003-05-08 WO claimed
US-20100168101-A1 OXINDOLE HYDRAZIDE MODULATORS OF PROTEIN TYROSINE PHOSPHATASES (PTPS) APPLIED RESEARCH SYSTEMS ARS HOLDING N.V. (NL) 2010-07-01 US disclosed
US-7696231-B2 Oxindole hydrazide modulators of protein tyrosine phosphatases (PTPs) LABORATOIRES SERONO SA (CH) 2010-04-13 US disclosed
US-20050043388-A1 Oxindole hydrazide modulators of protein tyrosine phosphatases (ptps) APPLIED RESEARCH SYSTEMS ARS HOLDING N.V. 2005-02-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050043388-A1 Oxindole hydrazide modulators of protein tyrosine phosphatases (ptps) PTPRO, PTPRE, PTPRZ1 MEN1 4402/4885KMT2A 3816/4885SMN1; SMN2 4885/4885
US-20100168101-A1 OXINDOLE HYDRAZIDE MODULATORS OF PROTEIN TYROSINE PHOSPHATASES (PTPS) PTPRO, PTPRE, PTPRZ1 MEN1 4405/4885KMT2A 3784/4885SMN1; SMN2 4885/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.